Protocol for the Stimulating β<sub>3</sub>-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease.
第一作者:
Kristen J,Bubb
第一单位:
Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
作者:
主题词
乙酰苯胺类(Acetanilides);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);双盲法(Double-Blind Method);人类(Humans);多中心研究(主题)(Multicenter Studies as Topic);外周动脉疾病(Peripheral Arterial Disease);生活质量(Quality of Life);随机对照试验(主题)(Randomized Controlled Trials as Topic);受体, 肾上腺素能β3(Receptors, Adrenergic, beta-3);噻唑类(Thiazoles);步行(Walking)
DOI
10.1136/bmjopen-2021-049858
PMID
34588252
发布时间
2022-05-31
- 浏览1

BMJ open
e049858页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文